PFM Health Sciences’s Visteon VC Stock Holding History

PFM Health Sciences’s Portfolio VC Stock Details VC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,313	Closed	-$1.76M	–	76
2019 Q4	$1.76M	Sell	20,313 -129,271	-86%	-$11.5M	0.08%	59
2019 Q3	$12.3M	Buy	+149,584	New	+$9.98M	0.36%	58

Other funds holding VC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PFM Health Sciences's VC Position: Q1 2020 in Review

PFM Health Sciences sold out of Visteon (VC) in Q1 2020, closing a stake of 20,313 shares — an estimated $1.76M sold.

PFM Health Sciences first reported a position in VC in Q3 2019 and held it in 2 quarters. The position peaked at $12.3M in Q3 2019. 194 funds tracked by Wall St. Rank hold VC as of Q1 2020.

PFM Health Sciences reported no remaining Visteon position as of Q1 2020 after selling out during the quarter.
PFM Health Sciences sold 20,313 Visteon shares in Q1 2020, an estimated $1.76M.
PFM Health Sciences first reported a position in Visteon in Q3 2019 and held it in 2 quarters.
PFM Health Sciences's Visteon position peaked at $12.3M in Q3 2019.
194 funds tracked by Wall St. Rank held Visteon as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.